Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal

NCT00480389 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma
Metastatic Disease

Interventions

DRUG: Sorafenib

Sponsor

University Health Network, Toronto

Collaborators

[object Object]